Thierry Langer

Title: Thierry Langer: Innovator in Viral Disease Treatment

Introduction

Thierry Langer is a notable inventor based in Oberschaeffolsheim, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of viral diseases. His innovative work has led to the development of a unique compound that holds promise for medical applications.

Latest Patents

Langer's most recent patent is titled "7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease." This invention relates to a compound with a general formula (A), which may exist in various forms such as pharmaceutically acceptable salts, solvates, polymorphs, codrugs, cocrystals, prodrugs, tautomers, racemates, enantiomers, or diastereomers. These compounds are designed to be effective in treating, ameliorating, or preventing viral diseases, and the patent also discloses specific combination therapies.

Career Highlights

Throughout his career, Thierry Langer has worked with prominent companies in the pharmaceutical industry. He has been associated with Savira Pharmaceuticals GmbH and F. Hoffmann-La Roche AG, where he has contributed to various research and development projects. His expertise in medicinal chemistry has been instrumental in advancing therapeutic options for patients.

Collaborations

Langer has collaborated with notable professionals in his field, including Andrea Wolkerstorfer and Oliver Szolar. These partnerships have enhanced his research efforts and contributed to the successful development of his patented compounds.

Conclusion

Thierry Langer's innovative work in the pharmaceutical industry, particularly in the area of viral disease treatment, showcases his dedication to improving healthcare outcomes. His contributions through patents and collaborations highlight the importance of innovation in medicine.